• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大不列颠哥伦比亚省囊性纤维化患者的伯克霍尔德菌属感染。30年经验。

Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience.

作者信息

Zlosnik James E A, Zhou Guohai, Brant Rollin, Henry Deborah A, Hird Trevor J, Mahenthiralingam Eshwar, Chilvers Mark A, Wilcox Pearce, Speert David P

机构信息

1 Centre for Understanding and Preventing Infection in Children/Department of Pediatrics, Faculty of Medicine, and.

出版信息

Ann Am Thorac Soc. 2015 Jan;12(1):70-8. doi: 10.1513/AnnalsATS.201408-395OC.

DOI:10.1513/AnnalsATS.201408-395OC
PMID:25474359
Abstract

RATIONALE

We have been collecting Burkholderia species bacteria from patients with cystic fibrosis (CF) for the last 30 years. During this time, our understanding of their multispecies taxonomy and infection control has evolved substantially.

OBJECTIVES

To evaluate the long-term (30 year) epidemiology and clinical outcome of Burkholderia infection in CF, and fully define the risks associated with infection by each species.

METHODS

Isolates from Burkholderia-positive patients (n=107) were speciated and typed annually for each infected patient. Microbiological and clinical data were evaluated by thorough review of patient charts, and statistical analyses performed to define significant epidemiological factors.

MEASUREMENTS AND MAIN RESULTS

Before 1995, the majority of new Burkholderia infections were caused by epidemic clones of Burkholderia cenocepacia. After implementation of new infection control measures in 1995, Burkholderia multivorans became the most prevalent species. Survival analysis showed that patients with CF infected with B. cenocepacia had a significantly worse outcome than those with B. multivorans, and a novel finding was that, after Burkholderia infection, the prognosis for females was significantly worse than for males.

CONCLUSIONS

B. multivorans and B. cenocepacia have been the predominant Burkholderia species infecting people with CF in Vancouver. The implementation of infection control measures were successful in preventing new acquisition of epidemic strains of B. cenocepacia, leaving nonclonal B. multivorans as the most prevalent species. Historically, survival after infection with B. cenocepacia has been significantly worse than B. multivorans infection, and, of new significance, we show that females tend toward worse clinical outcomes.

摘要

理论依据

在过去30年里,我们一直在收集囊性纤维化(CF)患者的伯克霍尔德菌属细菌。在此期间,我们对其多物种分类和感染控制的理解有了显著进展。

目的

评估CF患者伯克霍尔德菌感染的长期(30年)流行病学情况和临床结局,并全面确定每种细菌感染相关的风险。

方法

每年对伯克霍尔德菌阳性患者(n = 107)的分离株进行菌种鉴定和分型。通过全面查阅患者病历评估微生物学和临床数据,并进行统计分析以确定重要的流行病学因素。

测量指标和主要结果

1995年前,大多数新的伯克霍尔德菌感染由洋葱伯克霍尔德菌的流行克隆株引起。1995年实施新的感染控制措施后,多食伯克霍尔德菌成为最常见的菌种。生存分析表明,感染洋葱伯克霍尔德菌的CF患者结局明显比感染多食伯克霍尔德菌的患者差,一项新发现是,伯克霍尔德菌感染后,女性的预后明显比男性差。

结论

多食伯克霍尔德菌和洋葱伯克霍尔德菌一直是温哥华感染CF患者的主要伯克霍尔德菌属菌种。感染控制措施的实施成功预防了洋葱伯克霍尔德菌流行菌株的新感染,使非克隆性的多食伯克霍尔德菌成为最常见的菌种。从历史上看,感染洋葱伯克霍尔德菌后的生存率明显低于感染多食伯克霍尔德菌,而且,具有新意义的是,我们发现女性的临床结局往往更差。

相似文献

1
Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience.加拿大不列颠哥伦比亚省囊性纤维化患者的伯克霍尔德菌属感染。30年经验。
Ann Am Thorac Soc. 2015 Jan;12(1):70-8. doi: 10.1513/AnnalsATS.201408-395OC.
2
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.囊性纤维化患者感染洋葱伯克霍尔德菌复合群基因变种:基因变种III的强毒可传播菌株可取代多食伯克霍尔德菌。
Clin Infect Dis. 2001 Nov 1;33(9):1469-75. doi: 10.1086/322684. Epub 2001 Oct 4.
3
Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation.从囊性纤维化患者中分离出的洋葱伯克霍尔德菌复合体菌种的流行病学:与患者隔离相关的问题。
J Med Microbiol. 2004 Jul;53(Pt 7):663-668. doi: 10.1099/jmm.0.45557-0.
4
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.囊性纤维化患者中洋葱伯克霍尔德菌复合体定植的流行病学
Eur Respir J. 2004 Jun;23(6):851-6. doi: 10.1183/09031936.04.00118804.
5
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.洋葱伯克霍尔德菌和多食伯克霍尔德菌:对囊性纤维化患者生存的影响
Thorax. 2004 Nov;59(11):948-51. doi: 10.1136/thx.2003.017210.
6
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.意大利一家囊性纤维化中心的患者中洋葱伯克霍尔德菌复合体感染的流行病学及临床病程,特别是由不同洋葱伯克霍尔德菌菌株引起的感染。
J Clin Microbiol. 2004 Apr;42(4):1491-7. doi: 10.1128/JCM.42.4.1491-1497.2004.
7
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.英国囊性纤维化和非囊性纤维化患者中伯克霍尔德菌属(包括洋葱伯克霍尔德菌复合体成员)的患病率。
J Med Microbiol. 2017 Apr;66(4):490-501. doi: 10.1099/jmm.0.000458.
8
Epidemiology of Infections in People with Cystic Fibrosis in Canada between 2000 and 2017.2000年至2017年加拿大囊性纤维化患者感染的流行病学
Ann Am Thorac Soc. 2020 Dec;17(12):1549-1557. doi: 10.1513/AnnalsATS.201906-443OC.
9
Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.从囊性纤维化患者中分离出的洋葱伯克霍尔德菌、多食伯克霍尔德菌、栖稻伯克霍尔德菌和越南伯克霍尔德菌菌株具有不同的胞外酶产生谱。
APMIS. 2007 Apr;115(4):311-8. doi: 10.1111/j.1600-0463.2007.apm_603.x.
10
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.西地西菌属在囊性纤维化中的作用:流行病学和毒力的分子机制。
Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x.

引用本文的文献

1
State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists.最新综述:囊性纤维化患者护理的变革性变化:对传染病专家的启示
Clin Infect Dis. 2025 Jun 4;80(5):e65-e77. doi: 10.1093/cid/ciaf009.
2
Colony morphotype variation in implications for success of applications and therapeutics.菌落形态型变异对应用和治疗成功的影响。
J Bacteriol. 2025 May 22;207(5):e0052124. doi: 10.1128/jb.00521-24. Epub 2025 Apr 14.
3
-mediated inhibition of growth and biofilm formation.
介导的生长抑制和生物膜形成抑制。
J Bacteriol. 2025 Apr 17;207(4):e0011623. doi: 10.1128/jb.00116-23. Epub 2025 Mar 27.
4
Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy.囊性纤维化中细菌感染和微生物群的变化概况:在CFTR调节剂治疗时代何时使用抗生素。
Eur Respir Rev. 2024 Dec 4;33(174). doi: 10.1183/16000617.0068-2024. Print 2024 Oct.
5
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.临床微生物学实验室实用指南:更新的囊性纤维化患者呼吸道样本处理指南。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0021521. doi: 10.1128/cmr.00215-21. Epub 2024 Aug 19.
6
in cystic fibrosis children and adolescents: overall survival and immune alterations.在囊性纤维化的儿童和青少年中:总体生存率和免疫改变。
Front Cell Infect Microbiol. 2024 Jul 1;14:1374318. doi: 10.3389/fcimb.2024.1374318. eCollection 2024.
7
Glycoproteomic and proteomic analysis of reveals glycosylation events within FliF and MotB are dispensable for motility.糖蛋白质组学和蛋白质组学分析表明,FliF 和 MotB 内的糖基化事件对于运动性是可有可无的。
Microbiol Spectr. 2024 Jun 4;12(6):e0034624. doi: 10.1128/spectrum.00346-24. Epub 2024 May 6.
8
Identification of two distinct phylogenomic lineages and model strains for the understudied cystic fibrosis lung pathogen .鉴定两种不同的系统发育谱系和模式菌株,用于研究较少的囊性纤维化肺部病原体。
Microbiology (Reading). 2023 Aug;169(8). doi: 10.1099/mic.0.001366.
9
Activity of Finafloxacin against Panels of Respiratory Pathogens.非奈利酮对呼吸道病原体组的活性。
Antibiotics (Basel). 2023 Jun 23;12(7):1096. doi: 10.3390/antibiotics12071096.
10
Eradication of complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole.吸入阿米洛利和妥布霉素联合口服复方新诺明根除囊性纤维化患者的复合体。
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00055-2023. eCollection 2023 May.